Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Klatskin Tumor × Radiosurgery × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Brain Neoplasms 36 Pancreatic Neoplasms 29 Carcinoma, Non-Small-Cell Lung 29 Neoplasm Metastasis 26 Prostatic Neoplasms 23 Lung Neoplasms 18 Carcinoma, Hepatocellular 18 Melanoma 15 Glioblastoma 10 Breast Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 7 Neoplasms 7 Liver Neoplasms 7 Carcinoma, Renal Cell 7 Kidney Neoplasms 6 Head and Neck Neoplasms 6 Gliosarcoma 6 Sarcoma 5 Glioma 5 Central Nervous System Neoplasms 5 Uterine Cervical Neoplasms 4 Vulvar Neoplasms 3 Vaginal Neoplasms 3 Salivary Gland Neoplasms 3 Recurrence 3 Radiation Injuries 3 Pain 3 Ovarian Neoplasms 3 Fallopian Tube Neoplasms 3 Endometrial Neoplasms 3

Interventions

Fluorouracil 2 Capecitabine 2 tremelimumab 1 trametinib 1 temoporfin 1 durvalumab 1 dehydroftorafur 1 Sorafenib 1 Self Expandable Metallic Stents 1 Radiosurgery 1 Platinum 1 Oxaliplatin 1 N-Ac-CHAVC-NH2 1 Leucovorin 1 Hydroxychloroquine 1 Gemcitabine 1 Erlotinib Hydrochloride 1 Cisplatin 1 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03307538 2021-01-26

STRONG

Erasmus Medical Center

Phase NA Completed

Gastrointestinal

Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡